p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis (Q46866146)

25 December 2017

title

p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis (English)

1 reference

25 December 2017

0 references

1 reference

1

1 reference

25 December 2017

author name string

Kelly-Spratt KS

2

1 reference

25 December 2017

Furuya M

3

1 reference

25 December 2017

Parghi SS

4

1 reference

25 December 2017

Kemp CJ

5

1 reference

25 December 2017

language of work or name

English

0 references

publication date

3 December 2007

1 reference

25 December 2017

published in

Oncogene

1 reference

25 December 2017

volume

27

1 reference

25 December 2017

issue

22

1 reference

25 December 2017

page(s)

3145-3155

1 reference

25 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1210973

exact match

0 references

cites work

Tumor lymphangiogenesis and metastatic spread-new players begin to emerge.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

B cell-driven lymphangiogenesis in inflamed lymph nodes enhances dendritic cell mobilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Molecular control of lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Multistep skin cancer in mice as a model to study the evolution of cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

The crucial role of macrophages in lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Insights into the mechanisms of lymph node metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

T1alpha/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Suppression of VEGFR-3 signaling inhibits lymph node metastasis in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

The enhanced green fluorescent protein (eGFP) is minimally immunogenic in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

The role of tumor lymphangiogenesis in metastatic spread.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Induction of lymphangiogenesis in and around axillary lymph node metastases of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Lymphatic or hematogenous dissemination: how does a metastatic tumor cell decide?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

Alteration of cell cycle-dependent histone phosphorylations by okadaic acid. Induction of mitosis-specific H3 phosphorylation and chromatin condensation in mammalian interphase cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

7 January 2021

Tumours can act as adjuvants for humoral immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

7 January 2021

Opinion: emerging mechanisms of tumour lymphangiogenesis and lymphatic metastasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

7 January 2021

p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

7 January 2021

Inducible expression of an endothelial cell antigen on murine myocardial vasculature in association with interstitial cellular infiltration

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1210973

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1210973

1 reference

25 December 2017

PubMed ID

18059331

1 reference

25 December 2017